An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease
Tafere Mulaw Belete Department of Pharmacology, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence: Tafere Mulaw Belete Tel +251 918045943Email mutafere@yahoo.comAbstract: Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has a great potential...
Guardado en:
Autor principal: | Mulaw Belete T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d554f858af04c90b29dc8788b26d7cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
por: Rouamba T, et al.
Publicado: (2021) -
Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
por: Saghir SAM, et al.
Publicado: (2021) -
Glycopeptides as Potential Interventions for COVID-19
por: Demsie DG, et al.
Publicado: (2020) -
Hypercytokinemia and Pathogen–Host Interaction in COVID-19
por: Badawi A
Publicado: (2020) -
N-Acetylcysteine to Combat COVID-19: An Evidence Review
por: Shi Z, et al.
Publicado: (2020)